{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:54:19Z","timestamp":1792043659867,"version":"4.4.0"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.533070","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T14:32:54Z","timestamp":1600439574000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Lack of Racial Survival Differences in Metastatic Prostate Cancer in National Cancer Data Base (NCDB): A Different Finding Compared to Non-metastatic Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Toms","family":"Vengaloor Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan Z.","family":"Gordy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth T.","family":"Lirette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Gordy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Vijayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vani","family":"Vijayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Cancer J Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"Cancer J Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/bjc.2011.273","article-title":"Ethnic differences in prostate cancer","volume":"105","author":"Kheirandish","year":"2011","journal-title":"Br J Cancer."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semradonc.2016.08.002","article-title":"Prostate cancer genetics: variation by race, ethnicity, and geography","volume":"27","author":"Rebbeck","year":"2017","journal-title":"Sem Rad Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1002\/cam4.1451","article-title":"African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015","volume":"7","author":"Williams","year":"2018","journal-title":"Cancer Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","article-title":"Association of black race with prostate cancer\u2013specific and other-cause mortalityassociation of black race with prostate cancer\u2013specific and other-cause mortalityassociation of black race with prostate cancer\u2013specific and other-cause mortality","volume":"5","author":"Dess","year":"2019","journal-title":"JAMA Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1097\/ju.0000000000000416","article-title":"The relative importance of race compared to healthcare and social factors in predicting prostate cancer mortality: a random forest approach","volume":"202","author":"Hanson","year":"2019","journal-title":"J Urol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/jnci\/dji289","article-title":"Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment","volume":"97","author":"Edwards","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"B9","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.eururo.2005.06.001","article-title":"EAU guidelines on prostate cancer","volume":"48","author":"Aus","year":"2005","journal-title":"Eur Urol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<472::AID-CNCR27>3.0.CO;2-0","article-title":"Should African-American men be tested for prostate carcinoma at an earlier age than white men?","volume":"85","author":"Powell","year":"1999","journal-title":"Cancer."},{"key":"B11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0090-4295(96)00618-8","article-title":"The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: A multivariate analysis of positive surgical margins","volume":"49","author":"Powell","year":"1997","journal-title":"Urology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1158\/1055-9965.Epi-13-1328","article-title":"Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men","volume":"23","author":"Powell","year":"2014","journal-title":"Cancer Epidemiol Biomed Prev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.juro.2010.01.015","article-title":"Evidence supports a faster growth rate and\/or earlier transformation to clinically significant prostate cancer in black than in White American men, and influences racial progression and mortality disparity","volume":"183","author":"Powell","year":"2010","journal-title":"J Urol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.canlet.2017.11.011","article-title":"Prostate cancer health disparities: an immuno-biological perspective","volume":"414","author":"Kumar","year":"2018","journal-title":"Cancer Lett."},{"key":"B15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12894-016-0137-7","article-title":"Do African-American men need separate prostate cancer screening guidelines?","volume":"16","author":"Shenoy","year":"2016","journal-title":"BMC Urol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.18632\/oncotarget.14198","article-title":"Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians","volume":"8","author":"Shiina","year":"2017","journal-title":"Oncotarget."},{"key":"B17","unstructured":"Atlanta, GAAmerican Cancer SocietyProstate Statistics2018"},{"key":"B18","unstructured":"Atlanta, GAAmerican Cancer SocietyCancer Facts & Figures 20182018"},{"key":"B19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.15585\/mmwr.mm6823a4","article-title":"QuickStats: age-adjusted death rates* from prostate cancer, (\u2020) by race\/ ethnicity - national vital statistics system, United States, 1999-2017","volume":"68","author":"Hawkins","year":"2019","journal-title":"MMWMorb Mort Weekly Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jnma.2017.01.007","article-title":"Racial disparity in localized prostate cancer mortality","volume":"109","author":"Xin","year":"2017","journal-title":"J Natl Med Assoc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/01.ju.0000079761.56154.e5","article-title":"Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer","volume":"170","author":"Gaston","year":"2003","journal-title":"J Urol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/jnci\/djg094","article-title":"Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer","volume":"95","author":"Godley","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00005650-199511000-00002","article-title":"Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease","volume":"33","author":"Schapira","year":"1995","journal-title":"Med Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1002\/cncr.31026","article-title":"Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study","volume":"123","author":"Steele","year":"2017","journal-title":"Cancer."},{"key":"B25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11934-017-0724-5","article-title":"African-American prostate cancer disparities","volume":"18","author":"Smith","year":"2017","journal-title":"Curr Urol Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/jnci\/93.3.219","article-title":"Association of African-American ethnic background with survival in men with metastatic prostate cancer","volume":"93","author":"Thompson","year":"2001","journal-title":"J National Cancer Inst."},{"key":"B27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/jnci\/93.5.388","article-title":"Racial and ethnic differences in advanced-stage prostate cancer: the prostate cancer outcomes study","volume":"93","author":"Hoffman","year":"2001","journal-title":"J Natl Cancer Inst."},{"key":"B28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10552-019-01163-5","article-title":"Race and overall survival in men diagnosed with prostate cancer in the Department of Defense Military Health System, 1990-2010","volume":"30","author":"Alexander","year":"2019","journal-title":"Cancer Causes Cont."},{"key":"B29","first-page":"622","article-title":"Similar clinical outcomes in African-American and non-African-American males treated with suramin for metastatic prostate cancer","volume":"89","author":"Bergan","year":"1997","journal-title":"J Natl Med Assoc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.euf.2016.03.010","article-title":"Individual patient data analysis of randomized clinical trials: impact of black race on castration-resistant prostate cancer outcomes","volume":"2","author":"Spratt","year":"2016","journal-title":"Eur Urol Focus."},{"key":"B31","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.urology.2004.05.024","article-title":"Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer","volume":"64","author":"Thatai","year":"2004","journal-title":"Urology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00005392-199707000-00047","article-title":"Prostate specific antigen in black and white men after hormonal therapies for prostate cancer","volume":"158","author":"Fowler","year":"1997","journal-title":"J Urol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/(sici)1097-0045(19990901)40:4<218::aid-pros2>3.0.co;2-6","article-title":"Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group","volume":"40","author":"McLeod","year":"1999","journal-title":"Prostate."},{"key":"B34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1200\/jco.18.01279","volume":"37","author":"Halabi","year":"2019","journal-title":"J Clin Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1200\/JCO.2019.37.7_suppl.212","article-title":"Overall survival by race in chemotherapy-na\u00efve metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate or enzalutamide","volume":"37","author":"McNamara","year":"2019","journal-title":"J Clin Oncol."},{"key":"B36","first-page":"109","article-title":"Bone metastatic prostate cancer among African Americans: the survival equivalence parodox","volume":"55","author":"Gordy","year":"2019","journal-title":"Biomed Sci Instrum."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the national cancer database for outcomes research: a review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0022-5347(09)60185-3","article-title":"African American men have lower rate of treatment failure on primary LHRH agonist therpay for prostate cancer","volume":"181","author":"Sassani","year":"2009","journal-title":"J Urol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7812\/tpp\/11-096","article-title":"Black men have lower rates than white men of biochemical failure with primary androgen-deprivation therapy","volume":"15","author":"Sassani","year":"2011","journal-title":"Perm J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1056\/NEJM199810083391504","article-title":"Bilateral orchiectomy with or without flutamide for metastatic prostate cancer","volume":"339","author":"Eisenberger","year":"1998","journal-title":"N Engl J Med."},{"key":"B41","volume-title":"Survival Benefit for African-Americans With Advanced Prostate Cancer","year":"2018"},{"key":"B42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.urology.2004.04.014","article-title":"Impact of race on survival in men with metastatic hormone-refractory prostate cancer","volume":"64","author":"Halabi","year":"2004","journal-title":"Urology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.urology.2004.04.014","article-title":"Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC): Final PROCEED analysis","volume":"64","author":"Sartor","year":"2019","journal-title":"Am Soc Clin Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1200\/JCO","article-title":"Abi Race: a prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP)","volume":"37","author":"George","year":"2018","journal-title":"Am Soc Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0090-4295(93)90167-9","article-title":"Relapse on endocrine treatment in patients with stage D2 prostate cancer. Does second-line hormonal therapy affect survival?","volume":"41","author":"Matzkin","year":"1993","journal-title":"Urology."},{"key":"B46","first-page":"89","article-title":"The epidemiology of prostate cancer in black men","volume":"40","author":"Burks","year":"1992","journal-title":"Henry Ford Hosp Med J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrurol.2015.298","article-title":"Prostate cancer in men of African origin","volume":"13","author":"McGinley","year":"2016","journal-title":"Nat Rev Urol."},{"key":"B48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1022216119066","article-title":"Prostate cancer in black and white Americans","volume":"22","author":"Reddy","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/1055-9965.epi-12-1238","article-title":"Genes associated with prostate cancer are differentially expressed in African American and European American men","volume":"22","author":"Powell","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"15510","DOI":"10.3390\/ijms140815510","article-title":"Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men","volume":"14","author":"Farrell","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/pros.20052","article-title":"Explaining racial differences in prostate cancer in the United States: sociology or biology?","volume":"62","author":"Freedland","year":"2005","journal-title":"Prostate."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/annonc\/mdx041","article-title":"Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States","volume":"28","author":"Mahal","year":"2017","journal-title":"Ann Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/cncr.28042","article-title":"Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"119","author":"Barocas","year":"2013","journal-title":"Cancer."},{"key":"B54","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/01.ju.0000118907.64125.e0","article-title":"Racial\/ethnic disparities in the treatment of localized\/regional prostate cancer","volume":"171","author":"Underwood","year":"2004","journal-title":"J Urol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1002\/cncr.26103","article-title":"Racial\/ethnic differences in receipt of pelvic lymph node dissection among men with localized\/regional prostate cancer","volume":"117","author":"Hayn","year":"2011","journal-title":"Cancer."},{"key":"B56","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/pros.21314","article-title":"Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer","volume":"71","author":"Chornokur","year":"2011","journal-title":"Prostate."},{"key":"B57","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/jnci\/94.5.334","article-title":"Racial and ethnic disparities in the receipt of cancer treatment","volume":"94","author":"Shavers","year":"2002","journal-title":"J Natl Cancer Inst."},{"key":"B58","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.eururo.2017.07.023","article-title":"Racial disparity in delivering definitive therapy for intermediate\/high-risk localized prostate cancer: the impact of facility features and socioeconomic characteristics","volume":"71","author":"Friedlander","year":"2017","journal-title":"Eur Urol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/jamaoncol.2015.3384","article-title":"Racial differences in the surgical care of medicare beneficiaries with localized prostate cancer","volume":"2","author":"Schmid","year":"2016","journal-title":"JAMA Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/jamaoncol.2015.3615","article-title":"The meaning of race in prostate cancer treatment","volume":"2","author":"Brawley","year":"2016","journal-title":"JAMA Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.amjmed.2013.08.012","article-title":"\u2018Race' and prostate cancer mortality in equal-access healthcare systems","volume":"126","author":"Graham-Steed","year":"2013","journal-title":"Am J Med."},{"key":"B62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41391-018-0083-4","article-title":"Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer","volume":"22","author":"Krimphove","year":"2019","journal-title":"Prost Cancer Prost Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40615-014-0049-8","article-title":"Racial differences in age-related variations of testosterone levels among US males: potential implications for prostate cancer and personalized medication","volume":"2","author":"Hu","year":"2015","journal-title":"J Racial Ethn Health Disparities."},{"key":"B64","first-page":"45","article-title":"Serum testosterone levels in healthy young black and white men","volume":"76","author":"Ross","year":"1986","journal-title":"J Natl Cancer Inst."},{"key":"B65","first-page":"27","article-title":"Race and the Will Rogers phenomenon in prostate cancer","volume":"4","author":"Vijayakumar","year":"1998","journal-title":"Cancer J Sci Am."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.533070\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T14:33:00Z","timestamp":1600439580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.533070\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":65,"alternative-id":["10.3389\/fonc.2020.533070"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.533070","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"article-number":"533070"}}